Pharmacokinetic Profile of Rosemary Extract Supplement
Not Applicable
Not yet recruiting
- Conditions
- Pharmacokinetics
- Registration Number
- NCT05931341
- Lead Sponsor
- CJ CheilJedang
- Brief Summary
This study is a clinical trial to observe changes in biomarkers in the blood at pre- and post-supplementation of rosemary extract in healthy adults.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Healthy subjects aged between 25 and 55 years
- Non-smoker
- Body Mass Index (BMI) between 20 and 30 kg/m2
Exclusion Criteria
- Any history or presence of cardiovascular, pulmonary, gastro-intestinal, hepatic, renal, endocrine, metabolic, hematological, neurologic, psychiatric, systemic or infectious disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Concentration in plasma 24 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of rosemary extract influence CYP450 enzyme activity in pharmacokinetic studies?
How does rosemary extract supplementation compare to standard antioxidants in modulating oxidative stress biomarkers?
Which plasma biomarkers correlate with rosemary extract absorption and metabolism in NCT05931341?
What adverse events are associated with high-dose rosemary extract in healthy adults?
Are there synergistic pharmacokinetic interactions between rosemary extract and other herbal supplements like curcumin?